華友鈷業(603799.SH):第一大股東通過大宗交易、協議轉讓減持6.95%的股份
格隆匯6月1日丨華友鈷業(603799.SH)公佈,2020年6月1日,公司收到第一大股東大山公司的通知,大山公司於近日通過大宗交易減持其持有的1463.42萬股公司無限售流通股份,佔公司總股本的1.28%。同日,大山公司與澤友公司簽署了《股權轉讓協議》,大山公司將其持有的公司6472.0288萬股無限售流通股份(佔公司總股本的5.67%)轉讓給澤友公司。
大山公司通過大宗交易、協議轉讓合計減持上市公司7935.4488萬股,佔公司總股本的6.95%。此次權益變動不會導致公司控股股東或者實際控制人發生變化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.